Skip to main content

Fewer Complications at 18 Months Seen With Post-COVID-19 Vaccination Myocarditis

By Lori Solomon HealthDay Reporter

Medically reviewed by Carmen Pope, BPharm. Last updated on Aug 29, 2024.

via HealthDay

THURSDAY, Aug. 29, 2024 -- Patients with post-COVID-19 mRNA vaccination myocarditis show a lower frequency of cardiovascular complications than those with conventional myocarditis or post-COVID-19 myocarditis at 18 months, according to a study published online Aug. 26 in the Journal of the American Medical Association.

Laura Semenzato, from the French National Agency for the Safety of Medicines and Health Products and French National Health Insurance, and colleagues examined the prognosis and management of post-COVID-19 mRNA vaccination myocarditis compared to other types of myocarditis during 18 months of follow-up. The analysis included 4,635 individuals who were hospitalized for myocarditis, including 558 with postvaccine myocarditis, 298 with post-COVID-19 myocarditis, and 3,779 with conventional myocarditis.

The researchers found that patients with postvaccine myocarditis were younger than those with post-COVID-19 and conventional myocarditis (mean age, 25.9, 31.0, and 28.3 years, respectively) and were more frequently men (84, 67, and 79 percent, respectively). There was a lower standardized incidence of the composite clinical outcome (hospital readmission for myopericarditis, other cardiovascular events, and all-cause death) for patients with postvaccine myocarditis than those with conventional myocarditis (weighted hazard ratio, 0.55; 95 percent confidence interval, 0.36 to 0.86). Individuals with post-COVID-19 myocarditis had similar outcomes to conventional myocarditis (weighted hazard ratio, 1.04; 95 percent confidence interval, 0.70 to 1.52). Postvaccine myocarditis and post-COVID-19 myocarditis showed a similar trend for frequency of medical procedures and drugs prescribed posthospital discharge to that of patients with conventional myocarditis.

"Affected patients, mainly healthy young men, may require medical disease management for up to several months after hospital discharge," the authors write.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2025 HealthDay. All rights reserved.

Read this next

CVD Mortality Varies Among Asian Indian, Chinese, Filipino Americans

MONDAY, Aug. 4, 2025 -- Cardiovascular risk factor and disease mortality varies significantly among Asian Indian, Chinese, and Filipino Americans, with Filipino Americans having...

Study Estimates COVID-19 Vaccinations Prevented More Than 2.5 Million Deaths in 2020 to 2024

MONDAY, Aug. 4, 2025 -- COVID-19 vaccination during 2020 to 2024 was beneficial, but estimates are more conservative than previous calculations that focused on the first year of...

Risk of Long COVID Greater for Individuals With Social Risk Factors

THURSDAY, July 31, 2025 -- Individuals with social risk factors at the time of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection have increased risk for...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.